| About the author: |
M. І. Delva |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The aim of this study was to determine if abdominally obese patients taking pioglitazone after hospital admission for ischemic atherothrombotic hemispheric stroke had an improved clinical outcome. This prospective study evaluated 63 non-diabetic abdominally obese patients (class II obesity) aged 67.9±0.7 years (43% women) with acute ischemic atherothrombotic hemispheric stroke. Patients were matched for National Institutes of Health Stroke Scale score at admission, cerebral infarcts volume and pre-stroke disability. Patients were randomized into a control group (n=32) and a pioglitazone 30 mg/d group (n=31). Treatment with pioglitazone was initiated within 72 hours after the onset of stroke and continued up to 12 weeks. Favorable outcome was defined as modified Rankin scale (mRS) score ≤2 and Barthel index (BI) ≥85 at discharge, at 4 and 12 weeks. There was no any difference in functional outcomes at discharge. According to mRS, late favorable outcomes were more frequent in the pioglitazone group (OR 3.70; 95% CI 1.26 to 10.13; p=0.028 at 4 week; OR 3.68; 95% CI 1.18 to 10.60; p=0.04 at 12 week). Similar findings were observed with BI (OR 3.89; 95% CI 1.29 to 10.85; p=0.025 at 4 week; OR 4.04; 95% CI 1.22 to 12.11; p=0.03 at 12 week). Post-stroke use of pioglitazone is associated with improved late outcome in abdominally obese patients with acute atherothrombotic hemispheric stroke. |
| Tags |
abdominal obesity, ischemic stroke, outcome, pioglitazone |
| Bibliography |
- Adams J. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment / J. Adams, B. Bendixen, L. Kappelle [et al.] // Stroke. – 1993. – Vol. 24. – P. 35-41.
- Arenillas JF. The metabolic syndrome and stroke: potential treatment approaches / JF. Arenillas, MA. Moro, A. Dávalos // Stroke. – 2007. – Vol. 38. – P. 2196-2203.
- Berger J. The mechanisms of action of PPARs / J. Berger, DE. Moller // Annual Review of Medicine. – 2002. – Vol. 53. – P. 409–435.
- Blanco M. Increased plasma levels of 15-deoxi delta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke / M. Blanco, MA. Moro, A. Da´valos [et al.] // Stroke. – 2005. – Vol. 36. – P. 1189–1194.
- Blanquart C. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation / C. Blanquart, O. Barbier, JC. Fruchart [et al.] // The Journal of Steroid Biochemistry and Molecular Biology. – 2003. – Vol. 85. – P. 267–273.
- Bordet R. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases / R. Bordet, T. Ouk, O. Petrault [et al.] // Biochemical Society Transactions. – 2006. – Vol. 34. – P. 1341–1346.
- Broderick JP. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality / JP. Broderick, TG. Brott, JE. Duldner [et al.] // Stroke. – 1993. – Vol. 24. – P. 987-993.
- Collino M. Review: PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury / M. Collino, NS. Patel, C. Thiemermann // Therapeutic Advances in Cardiovascular Disease. – 2008. – Vol. 2. – P. 179-197.
- Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review / SE. Inzucchi // JAMA. – 2002. – Vol. 287. – P. 360–372.
- Kay R. Dichotomizing stroke outcomes based on self-reported dependency / R. Kay, KS. Wong, G. Perez [et al.] // Neurology. – 1997. – Vol. 49. – P. 1694 –1696.
- Kernan WN. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke / WN. Kernan, SE. Inzucchi, CM. Viscoli [et al.] // Stroke. – 2003. – Vol. 34. – P. 1431-1436.
- Lee J. Effects of thiazolidinediones on stroke recovery: a case-matched controlled study / J. Lee, M. Reding // Neurochemical Research. – 2007. – Vol. 32 (4-5). – P. 635-638.
- McColl BW. Systemic infection, inflammation and acute ischemic stroke / BW. McColl, SM. Allan, NJ. Rothwell // Neuroscience. – 2009. – Vol. 158 (3). – P. 1049-1061.
- Razinia T. Body mass index and hospital discharge outcomes after ischemic stroke / T. Razinia, J. Saver, D. Liebeskind [et al.] // Archives of Neurology. – 2007. – Vol. 64 (3). – P. 388-391.
- Rykała J. Wpływ wybranych czynników na jakość życia oraz stan funkcjonalny pacjentów po udarze mózgu / J. Rykała, A. Kwolek // Przegląd Medyczny Uniwersytetu Rzeszowskiego Rzeszów. – 2009. – Vol. 4. – P. 384–391.
- Литвиненко Н.В. Клініко-нейровізуалізаційні характеристики гострого періоду нелакунарних гемісферальних інсультів у осіб з ожирінням / Н.В. Литвиненко, М.Ю. Дельва, І.І. Дельва // Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії. – 2011. – T 11 (4). – C. 55-58.
|
| Publication of the article |
«World of Medicine and Biology» №4(41) 1 part 2013 year, 028-031 pages, index UDK 616.831-005.1-056.5 |
